The experimental vaccine could begin clinical testing in the U.S. as early as next week, and Pfizer could have results from the study next month
Pfizer Inc. said Tuesday it could have a coronavirus vaccine ready for use on an emergency basis in the fall if it proves to work safely in testing.
Testing of the vaccine, which has already started in Germany, could start in the U.S. as early as next week if health regulators sign off, Pfizer Chief Executive Albert Bourla said in an interview. Results from the study could come as early as next month, Mr. Bourla said.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Coronavirus live updates: Pfizer aims for millions of vaccine doses this year, Germany's infection rate risesCovid-19 has infected more than 3 million people around the world, killing at least 211,522 people.
Read more »
Pfizer beats first-quarter earnings estimates in race to develop coronavirus vaccine
Read more »
Stocks making the biggest moves in the premarket: 3M, Caterpillar, Pfizer, PepsiCo, Merck & moreThe stocks making the biggest moves in premarket trading include 3M, Caterpillar, Pfizer, PepsiCo, Merck, and more.
Read more »
Tom Hanks & Rita Wilson Are Making A Very Personal Sacrifice To Help Find A Coronavirus CureTom Hanks and his wife Rita Wilson’s blood is being used to develop a coronavirus vaccine.
Read more »
Human Trials Underway for Promising Coronavirus Vaccine That Could Be Ready in the FallIf scientists are able to prove that the vaccine is safe and effective, it could be available as soon as September
Read more »
Pfizer beats first-quarter earnings estimates in race to develop coronavirus vaccine
Read more »